Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7359369 | 0.82 | ITGB3 (0.74) | ITGB3ITGA2B | |
| SCHEMBL7835723 | 0.81 | ITGB3 (0.68) | ITGB3ITGA2B | |
| SCHEMBL7356494 | 0.80 | ITGB3 (0.68) | ITGB3ITGA2B | |
| SCHEMBL7364451 | 0.80 | ITGB3 (0.71) | ITGB3ITGA2B | |
| SCHEMBL7363768 | 0.80 | ITGB3 (0.74) | ITGB3ITGA2B | |
| SCHEMBL7356801 | 0.80 | ITGB3 (0.67) | ITGB3ITGA2B | |
| SCHEMBL7331297 | 0.79 | ITGB3 (1.00) | ITGB3ITGA2B | |
| SCHEMBL7356794 | 0.78 | ITGB3 (0.67) | ITGB3ITGA2B | |
| Iodide SCHEMBL9225689 | 0.78 | ITGB3 (0.98) | ITGB3ITGA2B | |
| SCHEMBL8789526 | 0.77 | ITGB3 (0.70) | ITGB3ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070238721-A1 | Highly Selective Novel Amidation Method | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070238721-A1 | Highly Selective Novel Amidation Method | NAAA, CPS1, COASY | ITGB3 4773/4885ITGA2B 4439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.